MREO - Mereo BioPharma Group regains compliance with Nasdaq's listing rule
- Mereo BioPharma Group ( NASDAQ: MREO ) stated Tuesday that it has regained compliance with Nasdaq's minimum $1 bid price requirement as notified by the exchange.
- Stock is up 2.9% in after-hours trading .
- Earlier: AstraZeneca considering bid for Mereo BioPharma – Report (update)
For further details see:
Mereo BioPharma Group regains compliance with Nasdaq's listing rule